Cocoa flavanols
Also called: cocoa extract, high-flavanol cocoa extract
Cocoa flavanols are flavanols from cocoa, including (-)-epicatechin and (+)-catechin. Supplements supply high-flavanol cocoa extract in capsules or tablets; many trials instead used flavanol-rich cocoa products or dark chocolate.
- Category
- Other
- Forms
- High-flavanol cocoa extract (capsules or tablets); flavanol-rich cocoa powder, beverages and dark chocolate in trials
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2017 Cochrane review pooled 35 RCTs (40 treatment comparisons, 1,804 mainly healthy adults) of flavanol-rich chocolate or cocoa products (30 to 1,218 mg flavanols/day) versus flavanol-free or low-flavanol controls for at least two weeks. [1]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels4 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in adults | B | A 2017 Cochrane review (35 RCTs, 1,804 mainly healthy adults, 2-18 weeks) found a small reduction (about 2 mmHg systolic and diastolic); moderate-quality evidence, with unexplained heterogeneity. [1] |
| Blood pressure and vascular function | B | A 2026 meta-analysis of 25 studies (1,167 participants; 10.6-1,680 mg/day) found systolic -2.73 and diastolic -1.85 mmHg, and better flow-mediated dilation; several authors work for a cocoa-food company. [2] |
| Endothelial function (flow-mediated dilation) | B | A 2019 meta-analysis of 15 articles (18 intervention arms) found FMD improved by 1.17%, with an inverted U-shaped dose response; most studies had risk-of-bias concerns. [3] |
| Cardiovascular events in older adults | C | COSMOS (21,442 older US adults, 500 mg flavanols/day, median 3.6 years) found no significant reduction in total cardiovascular events (HR 0.90); cardiovascular death was lower (HR 0.73), a secondary endpoint. [4] |
Main constituents: Cocoa flavanols, including (-)-epicatechin and (+)-catechin [3]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Cochrane-reviewed trials provided 30 to 1,218 mg flavanols (mean 670 mg) in 1.4 to 105 g of cocoa products per day. [1]
- COSMOS used a cocoa extract supplement providing 500 mg flavanols/day, including 80 mg (-)-epicatechin. [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
Identity, quality and standardization
- The EU-authorized claim requires products to provide at least a daily intake of 200 mg of cocoa flavanols with a degree of polymerization 1-10. [6]
Regulatory status
- EU: EFSA's NDA Panel (2012) concluded that "a cause and effect relationship has been established between the consumption of cocoa flavanols and maintenance of normal endothelium-dependent vasodilation" and that "200 mg of cocoa flavanols should be consumed daily" to obtain the effect. [5]
- EU: Regulation (EU) 2015/539 lists the claim "Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow" for cocoa beverages (with cocoa powder) or dark chocolate (authorized in 2013) and extends it to capsules or tablets of high-flavanol cocoa extract; both uses were restricted to the applicant for five years. [6]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Cocoa flavanols, including (-)-epicatechin and (+)-catechin Flavonoids (flavanols) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming cocoa flavanols (searched as cocoa, cacao, Theobroma and flavanol) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-30). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of cocoa or cocoa flavanols was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-30). [P4]
- The NTP Technical Reports index (TR-001 to TR-606) lists no study of cocoa or cocoa flavanols (checked 2026-10-30). [P5]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P6]
- Flavanol content with degree of polymerization 1-10 (at least 200 mg per daily amount) — Condition of use for the EU-authorized cocoa flavanol health claim (Regulation (EU) 2015/539). [P2]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Sun Y, et al. Dose-response relationship between cocoa flavanols and human endothelial function: a systematic review and meta-analysis of randomized trials. Food Funct 2019;10(10):6322-6330 (PMID 31524216), 2019-10-16. pubmed.ncbi.nlm.nih.gov
- Commission Regulation (EU) 2015/539 of 31 March 2015 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children's development and health and amending Regulation (EU) No 432/2012. Official Journal of the European Union L 88/7 (Publications Office of the EU), 2015-03-31. publications.europa.eu
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142, 2026-10-30. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/29/2026), 2026-10-29. ecfr.gov
Sources
- Ried K, Fakler P, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 2017;4:CD008893 (PMID 28439881), 2017-04-25. pubmed.ncbi.nlm.nih.gov
- Sakuda M, et al. Impact of cocoa flavanols on blood pressure and vascular function: an updated systematic review and meta-analysis of randomized controlled trials. J Nutr Health Aging 2026;30(11):100966 (PMID 42679502), 2026-09-01. pubmed.ncbi.nlm.nih.gov
- Sun Y, et al. Dose-response relationship between cocoa flavanols and human endothelial function: a systematic review and meta-analysis of randomized trials. Food Funct 2019;10(10):6322-6330 (PMID 31524216), 2019-10-16. pubmed.ncbi.nlm.nih.gov
- Sesso HD, et al. Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 2022;115(6):1490-1500 (PMID 35294962), 2022-06-07. pubmed.ncbi.nlm.nih.gov
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2012;10(7):2809 (abstract read in the OpenAlex record; the EFSA, Wiley and doi.org pages returned access errors on 2026-10-30), 2012-07. api.openalex.org
- Commission Regulation (EU) 2015/539 of 31 March 2015 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children's development and health and amending Regulation (EU) No 432/2012. Official Journal of the European Union L 88/7 (Publications Office of the EU), 2015-03-31. publications.europa.eu
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.